In cancer cells, signaling pathways can become aberrant due to mutations, overexpression, or loss of regulatory mechanisms. For example, mutations in genes encoding for tyrosine kinase receptors can lead to their constant activation, promoting unchecked cellular proliferation. Similarly, mutations in tumor suppressor genes like p53 can result in the failure to induce apoptosis, allowing cancer cells to survive and proliferate.
